Journal of Pharmacy and Bioallied Sciences (Jan 2024)

Efficacy of oral colchicine and intralesional hyaluronidase with and without ultrasound therapy in the management of oral submucous fibrosis—A comparative study

  • Malabika Shil,
  • Poulami Goswami,
  • Trupti Vijay Gaikwad,
  • Gargi Jadaun,
  • T Sridhar,
  • Basudhara Bandyopadhyay,
  • Pratik Surana

DOI
https://doi.org/10.4103/jpbs.jpbs_879_23
Journal volume & issue
Vol. 16, no. 5
pp. 586 – 588

Abstract

Read online

Aim: To determine the therapeutic effect and efficacy of oral colchicine tablet and intralesional injection of hyaluronidase with and without ultrasound therapy in the clinical course of oral submucous fibrosis. Materials and Methods: This comparative study involving 45 human participants was divided into three equal groups. The participants in group 1 received oral colchicine and intralesional hyaluronidase. The participants in group 2 received oral colchicine, intralesional hyaluronidase, and ultrasound therapy. The group 3 participants were treated with intralesional dexamethasone and hyaluronidase. Intergroup assessments were done using repeated measures of ANOVA test, where P value of <0.05 was considered as statistically significant difference. Results: Group 2 patients had maximum improvement with respect to all the parameters. Conclusion: Therapeutic ultrasound can be given effectively as an adjunct therapy along with conventional therapy in OSMF patients.

Keywords